---
layout: post
title: USAN Watch - April 2012
date: '2012-04-11T12:37:00.000+01:00'
author: John Overington
tags:
- INNS and USANS
modified_time: '2012-05-10T21:36:33.170+01:00'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-8123125590119907584
blogger_orig_url: http://chembl.blogspot.com/2012/04/usan-watch-april-2012.html
---

<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><span class="Apple-style-span" style="font-family: inherit;"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></span></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for April 2012 have just been published.</span><br />
<span class="Apple-style-span" style="font-family: inherit;"><br /></span><br />
<table border="1"><tbody>
<tr><td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Structure</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/alirocumab.pdf"><span class="Apple-style-span" style="font-family: inherit;">alirocumab</span></a></td><td><span class="Apple-style-span" style="font-family: inherit;">REGN-727, SAR-0236553</span></td><td></td><td><span class="Apple-style-span" style="font-family: inherit;">mAb</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">PCSK9</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/birinapant.pdf"><span class="Apple-style-span" style="font-family: inherit;">birinapant</span></a></td><td><span class="Apple-style-span" style="font-family: inherit;">TL-32711</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-TwAhM7iS7lc/T4Vy6vd-cNI/AAAAAAAABsY/v4VPeCYHHsw/s1600/birinipant.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-TwAhM7iS7lc/T4Vy6vd-cNI/AAAAAAAABsY/v4VPeCYHHsw/s1600/birinipant.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">IAPs</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/bevenopran.pdf"><span class="Apple-style-span" style="font-family: inherit;">bevenopran</span></a></td><td><span class="Apple-style-span" style="font-family: inherit;">CB-5945</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-xXTZmRMqzR4/T469XD90EvI/AAAAAAAABuM/L8rA95zFKRI/s1600/bevenopran.png"><img border="0" src="http://1.bp.blogspot.com/-xXTZmRMqzR4/T469XD90EvI/AAAAAAAABuM/L8rA95zFKRI/s1600/bevenopran.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">mu opioid receptor</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/camicinal.pdf"><span class="Apple-style-span" style="font-family: inherit;">camicinal</span></a></td><td>GSK-962040B</td><td><div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-R9RCpftx-k8/T4uRvo5VchI/AAAAAAAABt8/HCvVSjcRPc0/s1600/Camicinal.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-R9RCpftx-k8/T4uRvo5VchI/AAAAAAAABt8/HCvVSjcRPc0/s1600/Camicinal.png" /></a></div>
<span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><br /></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td>motilin receptor</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/cindunistat.pdf"><span class="Apple-style-span" style="font-family: inherit;">cindunistat</span></a></td><td><span class="Apple-style-span" style="font-family: inherit;">PHA-84250, SC-084250, PF-00572986 &nbsp; <span style="font-size: 12pt;">&nbsp;</span></span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-oHYGzFRJkYE/T4VzGbwksFI/AAAAAAAABsg/e-9BqJBEQc4/s1600/cindunistat.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-oHYGzFRJkYE/T4VzGbwksFI/AAAAAAAABsg/e-9BqJBEQc4/s1600/cindunistat.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td>NOS?</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/danirixin.pdf"><span class="Apple-style-span" style="font-family: inherit;">danirixin</span></a></td><td><span style="font-family: inherit;">GSK-1325756B &nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-AIRnzRDw05U/T4VzSL1q4aI/AAAAAAAABso/SXilUcgUUG0/s1600/danirixin.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-AIRnzRDw05U/T4VzSL1q4aI/AAAAAAAABso/SXilUcgUUG0/s1600/danirixin.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">CXCR2</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/demcizumab.pdf"><span class="Apple-style-span" style="font-family: inherit;">demcizumab</span></a></td><td><span style="font-family: inherit;">OMP-21M18 &nbsp;&nbsp;</span></td><td></td><td><span class="Apple-style-span" style="font-family: inherit;">mAb</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">DLL4</span></td></tr>
<tr><td><span class="Apple-style-span" style="font-family: inherit;"><a href="http://www.ama-assn.org/resources/doc/usan/elubrixin.pdf">elubrixin</a>, <a href="http://www.ama-assn.org/resources/doc/usan/elubrixin-tosylate.pdf">elubrixin tosylate</a></span></td><td><span style="font-family: inherit;">SB-656933-AAF,&nbsp;SB-656933-AAA&nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-nlhFXhZzqDQ/T4VzW0pbrYI/AAAAAAAABsw/NNKs44a4dV8/s1600/elubrixin.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-nlhFXhZzqDQ/T4VzW0pbrYI/AAAAAAAABsw/NNKs44a4dV8/s1600/elubrixin.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">CXCR2</span></td></tr>
<tr><td><span class="Apple-style-span" style="font-family: inherit;"><a href="http://www.ama-assn.org/resources/doc/usan/etirinotecan-pegol.pdf">etirinotecan pegol</a>, <a href="http://www.ama-assn.org/resources/doc/usan/etirinotecan-pegol-tetrahydrochloride.pdf">etirinotecan pegol tetrahydrochloride</a>, <a href="http://www.ama-assn.org/resources/doc/usan/etirinotecan-pegol-tetratriflutate.pdf">etirinotecan pegol tetratriflutate</a></span></td><td><span style="font-family: inherit;">NKTR-102 &nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-DOmOY8MjSxY/T4VzfWSHfhI/AAAAAAAABs4/kqEaviYnkoQ/s1600/etirinotecan+pegol.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-DOmOY8MjSxY/T4VzfWSHfhI/AAAAAAAABs4/kqEaviYnkoQ/s1600/etirinotecan+pegol.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">natural product-derived small molecule&nbsp;</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">topoisomerase 1</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/fasinumab.pdf"><span class="Apple-style-span" style="font-family: inherit;">fasinumab</span></a></td><td><span style="font-family: inherit;">REGN-475, SAR-164877 &nbsp; &nbsp;</span></td><td></td><td><span class="Apple-style-span" style="font-family: inherit;">mAb</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">NGF</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/lomibuvir.pdf"><span class="Apple-style-span" style="font-family: inherit;">lomibuvir</span></a></td><td><span style="font-family: inherit;">VX-222 &nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-ReYxHY00FYQ/T4VzlgR0S9I/AAAAAAAABtA/OPr_X-zUmmA/s1600/lomibuvir.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-ReYxHY00FYQ/T4VzlgR0S9I/AAAAAAAABtA/OPr_X-zUmmA/s1600/lomibuvir.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">HCV NS5B polymerase</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/mafodotin.pdf"><span class="Apple-style-span" style="font-family: inherit;">mafodotin</span></a></td><td><span style="font-family: inherit;">mc-MMAF, mcMMAF, SGD-1269, monomethyl auristatin F</span></td><td><div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-a-cibpXVxVc/T5EUlSGDh2I/AAAAAAAABuY/CkNOKRdHJkE/s1600/mafodotin.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://2.bp.blogspot.com/-a-cibpXVxVc/T5EUlSGDh2I/AAAAAAAABuY/CkNOKRdHJkE/s1600/mafodotin.png" /></a></div>
<span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><br /></span></td><td><span class="Apple-style-span" style="font-family: inherit;">peptide</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td>tubulin</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/neceprevir.pdf"><span class="Apple-style-span" style="font-family: inherit;">neceprevir</span></a></td><td><span style="font-family: inherit;">ACH-0142684 &nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-uhRIm0jIzdg/T4V0QcTVg7I/AAAAAAAABtI/abdQJMeJvzY/s1600/neceprevir.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-uhRIm0jIzdg/T4V0QcTVg7I/AAAAAAAABtI/abdQJMeJvzY/s1600/neceprevir.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pexastimogene-devacirepvec.pdf"><span class="Apple-style-span" style="font-family: inherit;">pexastimogene devacirepvec</span></a></td><td><span style="font-family: inherit;">JX-594 &nbsp;&nbsp;</span></td><td></td><td><span class="Apple-style-span" style="font-family: inherit;">virus</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/rabusertib.pdf"><span class="Apple-style-span" style="font-family: inherit;">rabusertib</span></a></td><td><span style="font-family: inherit;">LY-2603618 &nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-JcOkpM9ytys/T4V0ZjLGoDI/AAAAAAAABtQ/ExaW8vtCcBU/s1600/rabusertib.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-JcOkpM9ytys/T4V0ZjLGoDI/AAAAAAAABtQ/ExaW8vtCcBU/s1600/rabusertib.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">CHEK1 CHEK2</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/rilimogene-galvacirepvec.pdf"><span class="Apple-style-span" style="font-family: inherit;">rilimogene galvacirepvec</span></a></td><td><span style="font-family: inherit;">Prostvac-V &nbsp;&nbsp;</span></td><td></td><td><span class="Apple-style-span" style="font-family: inherit;">virus</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/sebelipase-alfa.pdf"><span class="Apple-style-span" style="font-family: inherit;">sebelipase alfa</span></a></td><td><span style="font-family: inherit;">SBC-102 &nbsp;&nbsp;</span></td><td></td><td><span class="Apple-style-span" style="font-family: inherit;">enzyme</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/vercirnon.pdf"><span class="Apple-style-span" style="font-family: inherit;">vercirnon</span></a></td><td><span style="font-family: inherit;">GSK-1605786, CCX-282 &nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-lLVZfS4bJkU/T4V0jRWskHI/AAAAAAAABtY/f5IdSUiYP3w/s1600/vercirnon.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-lLVZfS4bJkU/T4V0jRWskHI/AAAAAAAABtY/f5IdSUiYP3w/s1600/vercirnon.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">CCR9</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/vintafolide.pdf"><span class="Apple-style-span" style="font-family: inherit;">vintafolide</span></a></td><td><span style="font-family: inherit;">EC-145 &nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-oBDZKXCyiSQ/T4V0qWQ_H_I/AAAAAAAABtg/qKfWpWg9JPU/s1600/vintafolide.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-oBDZKXCyiSQ/T4V0qWQ_H_I/AAAAAAAABtg/qKfWpWg9JPU/s1600/vintafolide.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">natural product-derived small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">Folate Receptor, tubulin</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/vorsetuzumab.pdf">vorsetuzumab</a></td><td>SGN-70</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"></span></td><td>mAb</td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">CD70</span></td></tr>
<tr><td><span class="Apple-style-span" style="font-family: inherit;"><a href="http://www.ama-assn.org/resources/doc/usan/vorsetuzumab-mafodotin.pdf">vorsetuzumab mafodotin</a></span></td><td><span style="font-family: inherit;">SGN-75&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"></span></td><td>mAb ADC</td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">CD70</span></td></tr>
</tbody></table>
<br />
<div>
I knocked this together during a meeting ( :O ) so there may be some errors, feel free to add more detail/corrections in the comments.<br />
<br />
A couple of extras have appeared on the USAN web page recently.... so I've updated the table above appropriately. Well, two more have appeared on the USAN site! Will add these soon. It looks like there are some subtle rejigging of the business rules for USANs - in particular the assignment of a USAN for the drug conjugate mafoditin - I do wish that the USAN office would reply to emailed questions.....</div>